- Home
- Products
Vitrakvi (Larotrectinib)
Vitrakvi (Larotrectinib)
- Medicine Name: Vitrakvi
- Generic Name: Larotrectinib
- Dosage Form & Strength: Capsules – 25 mg and 100 mg
- Manufactured By: Bayer Pharmaceuticals
Vitrakvi is an oral kinase inhibitor indicated for the treatment of adult and pediatric patients with solid tumors that:
- Exhibit NTRK gene fusion (without known acquired resistance mutations)
- Are metastatic or where surgical resection is likely to cause severe morbidity
- Have no satisfactory alternative treatment options or have progressed following prior therapy
Recommended Dosage
- Adults and pediatric patients with BSA ≥1.0 m²: 100 mg twice daily
- Pediatric patients with BSA <1.0 m²: 100 mg/m² twice daily
- Take orally, with or without food
- Swallow capsules whole. Do not chew, crush, or break
- Do not retake a missed dose within 6 hours of the next scheduled dose
- If vomiting occurs, resume with the next scheduled dose
- Central Nervous System Effects: May include mood changes, dizziness, sleep disorders, or cognitive impairment. Avoid driving or operating machinery if symptoms occur.
- Fracture Risk: Monitor for pain or mobility changes. No conclusive data on bone healing.
- Liver Enzyme Elevation: Monitor AST/ALT levels every 2 weeks during the first month, then monthly.
- Pregnancy Risk: Larotrectinib may cause fetal harm. Use effective contraception during treatment and for 7 days after the last dose.
Required to Import Vitrakvi into India:
- Valid medical prescription from a licensed doctor
- Diagnostic reports indicating NTRK gene fusion
- Government-issued ID proof
Availability in India:
Vitrakvi can be imported under India’s Named Patient Program. Global Rare Meds ensures compliant access in cities including Mumbai, Delhi, Chennai, Hyderabad, Kolkata, Pune, Bengaluru, and more.
📧 info@globalraremeds.com
📞 +91-99675 15602 (Call/WhatsApp)
Global Rare Meds sources Vitrakvi (Larotrectinib) from certified global suppliers in the USA, Canada, Europe, and Australia, with delivery coordinated through our licensed fulfillment center in Ambernath, Thane District.
We provide:
- Regulatory-compliant import handling
- Secure and temperature-controlled shipping
- Verified prescriptions reviewed by licensed pharmacists
- Timely doorstep delivery
Q: What is the generic name of Vitrakvi®?
A: Larotrectinib
Q: Who manufactures Vitrakvi®?
A: Bayer Pharmaceuticals
Q: What is Vitrakvi® used for?
A: Treatment of solid tumors with NTRK gene fusion in both adult and pediatric patients.
Q: Is Vitrakvi® FDA-approved?
A: Yes, it was approved by the FDA on November 26, 2018.
Q: What dosages are available?
A: Capsules – 25 mg and 100 mg
Q: What are common side effects of Vitrakvi®?
A: Diarrhea, dizziness, nausea, fatigue, constipation, muscle pain, low calcium levels, and changes in RBC/WBC counts.
Q: How should Vitrakvi® be stored?
A: Store at 20°C to 25°C (68°F to 77°F). Permitted range: 15°C to 30°C (59°F to 86°F)
Q: What is the cost of Vitrakvi® in India?
A: Pricing may vary. Contact info@globalraremeds.com or +91-99675 15602 for the latest quote.
Q: Can I legally buy Vitrakvi® online in India?
A: Yes. With a valid prescription, Global Rare Meds can facilitate the legal import of Vitrakvi® through international suppliers.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
